Lucy Side
Overview
Explore the profile of Lucy Side including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
2191
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clark S, Cuthill V, Hawkins J, Hyer W, Latchford A, Sinha A, et al.
BJC Rep
. 2024 Nov;
1(1):10.
PMID: 39516584
No abstract available.
2.
Bancroft E, Page E, Brook M, Pope J, Thomas S, Myhill K, et al.
BJU Int
. 2024 Jun;
134(3):484-500.
PMID: 38839570
Objectives: To report the long-term outcomes from a longitudinal psychosocial study that forms part of the 'Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted Screening in men...
3.
Dias A, Brook M, Bancroft E, Page E, Chamberlain A, Saya S, et al.
BJUI Compass
. 2023 Apr;
4(3):361-373.
PMID: 37025481
Objectives: The relation of serum androgens and the development of prostate cancer (PCa) is subject of debate. Lower total testosterone (TT) levels have been associated with increased PCa detection and...
4.
Bernkopf M, Abdullah U, Bush S, Wood K, Ghaffari S, Giannoulatou E, et al.
Nat Commun
. 2023 Feb;
14(1):853.
PMID: 36792598
Following the diagnosis of a paediatric disorder caused by an apparently de novo mutation, a recurrence risk of 1-2% is frequently quoted due to the possibility of parental germline mosaicism;...
5.
Philpott S, Raikou M, Manchanda R, Lockley M, Singh N, Scott M, et al.
J Med Genet
. 2022 Nov;
60(5):440-449.
PMID: 36319079
Background: Our study aimed to establish 'real-world' performance and cost-effectiveness of ovarian cancer (OC) surveillance in women with pathogenic germline variants who defer risk-reducing bilateral salpingo-oophorectomy (RRSO). Methods: Our study...
6.
Burnell M, Gaba F, Sobocan M, Desai R, Sanderson S, Loggenberg K, et al.
BJOG
. 2022 Jul;
129(12):1970-1980.
PMID: 35781768
Objective: Ashkenazi-Jewish (AJ) population-based BRCA testing is acceptable, cost-effective and amplifies primary prevention for breast & ovarian cancer. However, data describing lifestyle impact are lacking. We report long-term results of...
7.
Gaba F, Oxley S, Liu X, Yang X, Chandrasekaran D, Kalsi J, et al.
Diagnostics (Basel)
. 2022 May;
12(5).
PMID: 35626184
Unselected population-based personalised ovarian cancer (OC) risk assessments combining genetic, epidemiological and hormonal data have not previously been undertaken. We aimed to understand the attitudes, experiences and impact on the...
8.
Santana Dos Santos E, Spurdle A, Carraro D, Briaux A, Southey M, Torrezan G, et al.
NPJ Breast Cancer
. 2022 Jan;
8(1):9.
PMID: 35039532
At least 10% of the BRCA1/2 tests identify variants of uncertain significance (VUS) while the distinction between pathogenic variants (PV) and benign variants (BV) remains particularly challenging. As a typical...
9.
Bancroft E, Page E, Brook M, Thomas S, Taylor N, Pope J, et al.
Lancet Oncol
. 2021 Oct;
22(11):1618-1631.
PMID: 34678156
Background: Lynch syndrome is a rare familial cancer syndrome caused by pathogenic variants in the mismatch repair genes MLH1, MSH2, MSH6, or PMS2, that cause predisposition to various cancers, predominantly...
10.
Shaunak M, Side L, Afzal N, Davies J
J Pediatr Endocrinol Metab
. 2021 Oct;
35(1):131-134.
PMID: 34674413
Objectives: To report an atypical presentation of a pathogenic gene variant in siblings not fulfilling the clinical diagnostic criteria for Peutz-Jeghers Syndrome (PJS) Case Presentation: Two siblings presented with prepubertal...